LASR Labs

LASR Labs is a biotechnology company developing a precision drug delivery platform designed to improve the therapeutic index of potent medicines. The company's proprietary Light-Activated Site-specific Release (LASR) technology utilizes light to trigger the release of therapeutic payloads at specific anatomical locations, minimizing systemic toxicity. By enabling the use of highly potent drugs that were previously limited by side effects, LASR Labs aims to transform treatments in oncology, ophthalmology, and other localized diseases. The platform is compatible with various modalities, including small molecules and biologics, and is currently in the pre-clinical stage of development.